SCHEMBL29200341

SCHEMBL29200341

NC(=O)c1ccccc1NCc1cccc(NC(=O)c2ccc(Cl)cc2)c1

nearest known ligand 0.67

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ PARP1 P09874 3/20 0.67
▸ PARP2 Q9UGN5 2/20 0.67
▸ AURKA O14965 8/20 0.66
▸ AURKB Q96GD4 7/20 0.66
▸ SIRT2 Q8IXJ6 2/20 0.57
▸ MEN1 O00255 2/20 0.56
▸ KMT2A Q03164 2/20 0.56
▸ AGTR1 P30556 1/20 0.56
▸ RPS6KB1 P23443 6/20 0.56
▸ PDPK1 O15530 1/20 0.56
▸ RXFP1 Q9HBX9 2/20 0.54
▸ KDM4E B2RXH2 2/20 0.53
▸ GAA P10253 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30802632 1.00 PARP1 (0.67) PARP1PARP2AURKAAURKBSIRT2
SCHEMBL29200315 0.90 AURKA (0.67) PARP1PARP2AURKAAURKBSIRT2
SCHEMBL30802649 0.90 AURKA (0.67) PARP1PARP2AURKAAURKBSIRT2
SCHEMBL29200358 0.89 PARP1 (0.72) PARP1PARP2AURKAAURKBSIRT2
SCHEMBL30802655 0.86 PARP1 (0.65) PARP1AURKAAURKBSIRT2MEN1
SCHEMBL29200346 0.86 PARP1 (0.65) PARP1AURKAAURKBSIRT2MEN1
SCHEMBL29200319 0.84 MEN1 (0.75) PARP1AURKAAURKBSIRT2MEN1
SCHEMBL30802613 0.84 MEN1 (0.75) PARP1AURKAAURKBSIRT2MEN1
SCHEMBL29200350 0.83 PARP1 (0.78) PARP1PARP2AURKAAURKBSIRT2
SCHEMBL29200354 0.81 PARP1 (0.71) PARP1AURKAAURKBSIRT2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117658868-A Benzamide derivative and preparation method and application thereof 中山大学 2024-03-08 — — CN claimed
CN-117658868-A Benzamide derivative and preparation method and application thereof 中山大学 2024-03-08 — — CN disclosed
Send feedback